The company SINEKS MEDICAL DOO from Belgrade proudly presents its European partner, the family company RegenLab® from Switzerland with headquarters in Lausanne, which deals with the development and production of medical devices and original laboratory equipment of innovative biotechnology.
In its offer, RegenLab® has created a wide range of products for biological cell therapy based on a thixotropic separate gel that is specially designed for the production of A-PRP, i.e. autologous plasma enriched with platelets, as well as other products from patients’ own blood.
Own growth factors, activated from α-granules of platelets, significantly contribute to the natural process of healing, recovery and tissue regeneration.
Regen Lab® is known as a leading supplier of patented technology for the production of Autologous Platelet-Rich Plasma (A-PRP). The technology is based on the processing of patients’ own blood, in order to use platelets, cells and healing proteins in various medical fields such as sports medicine, wound treatment and aesthetics.
A-PRP is also used in combination with freshly extracted cells (bone marrow, adipose tissue, skin cells…).
PRP therapy Regenlab
Platelets are key factors in the recovery mechanisms of hard and soft tissue. They provide the necessary growth factors (FGF, PDGF, TGF – β, EGF, VEGF, IGF) involved in:
• Stem cell migration, differentiation and reproduction
• Stimulation of cells such as fibroblasts and endothelial cells, in order to encourage new extracellular matrix deposition and neo-vascularization.
Plasma contains many factors necessary for cell survival, such as: nutrients, vitamins, hormones, electrolytes and proteins. Among the plasma proteins, there are molecules necessary for the coagulation process and the creation of fibrin polymer, which will serve as the basis for cell migration, differentiation and their reproduction.
FORMATION OF GEL
With the action of trombone enzyme, macromolecules of fibrinogen that are soluble in plasma are converted into fibrin monomers that will polymerize into a network and then form a three-dimensional network.
Regen Lab has created a wide range of products to meet the needs of end users. The products are adapted to different indications for private clinics and hospitals.
Orthopedics
Sports medicine
Aesthetics
Wound healing
Odontology
Surgery
Plastic surgery
Cardiovascular surgery
Neurosurgery
Maxillofacial surgery
Injection of autologous plasma enriched with platelets
(A-PRP) RegenLab set
USE:
It is combined with Autologous Thrombin Serum (ATS) to make a biological glue for:
DRY EYE SYNDROME
Dry eye is a condition characterized by quantitative reduction and/or quantitative changes in the amount of tear film that has the function of moistening the eye surface. This condition can be harmful because it can cause injuries to the surface of the eye – the tear film will “break” due to constant exposure to dehydration of the corneal epithelium and anterior palpebral conjunctiva.
Autologous plasma enriched with platelets (A-PRP) used in the form of eye drops, provides simulation of artificial tears with the function of lubrication, cleaning and antiseptic effect.
ULCERS
Application of Autologous platelet-rich plasma (A-PRP) in the form of a gel is particularly effective in the treatment of ulcers (neuropathic, venous and pressure ulcers), which initiates the healing process of even chronic wounds that do not respond to standard methods of treatment. It reduces pain and inflammation and shortens hospitalization time.
Fleksibilan i reproduktivan sistem koncentracije matičnih ćelija iz koštane srži
RegenExtracell BMC & GLUE obezbeđuje uspešno dobijanje 74% mononuklearnih ćelija (MNC) i 87% mezenhimalnih matičnih ćelija (MSC) iz aspirata koštane srži.
RegenExtracell BMC & GLUE je dokazano uspešno nadoknadio koštane defekte sa 79% do 100% uspešnosti uz period izlečenja od svega 2,5 meseca.
Autologni trombonski serum
Aktivacija trombocita fiziološkim putem
Pospešuje proces zaceljivanja fibrinskim gelom pripremljenim od sopstvene plazme obogaćene trombocitima koja je aktivirana autolognim trombinskim serumom.
Bezbedna i delotvorna autologna plazma obogaćena trombocitima sa smanjenim brojem leukocita za primenu na muskuloskeletalnom sistemu
CellularMatrix sinergistički kombinuje komplementarne efekte hijaluronske kiseline (HA) i autologne plazme obogaćene trombocitima (A-PRP®) da obezbedi dodatnu dobrobit pacijentima koji pate od osteoartritisa.
Specijalno pripremljen sistem za pripremu HA/A-PRP kojim se trenutno u samo jednom koraku, u zatvorenom sterilnom sistemu, formira mreža hijaluronske kiseline na kojoj su raspršeni trombociti koji dalje povoljno utiču na ostale ćelije tkiva.
CellularMatrix je registrovano medicinsko sredstvo koje sadrži 2 ml prirodne neumrežene 2% hijaluronske kiseline u koncentraciji od 20mg/ml (40mg ukupno) pored tiksotropnog separatnog gela za razdvajanje ćelija i antikoagulacionog rastvora natrijum citrata
ArthroVisc je sterilna i nepirogenirana formulacija visoko koncentrisane, visokomolekularne hijaluronske kiseline dobijene fermentacijom u fosfatnom fiziološkom puferu. Dostupan je u pojedinačnom pakovanju u špricu od 2ml.
ArthroVisc je namenjen isključivo za jednokratnu upotrebu. Primenjuje se u skladu sa lokalnim zdravstvenim propisima, periartikularno od strane posebno za to obučenog lekara sa ili bez kontrole ultra zvukom i sa sterilnim iglama za jednokratnu upotrebu.
REGENLAB: Informacije: office@sineksmedical.com
tel: 065 65 23 111
U BEOGRADU:
U NOVOM SADU:
U NIŠU: